Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Phase Study on the Safety and Tolerance of a Novel Probiotic in Healthy Adults: Open-Label and Double-Blind, Placebo-Controlled Study

NCT07566884 is registered in ClinicalTrials.gov with Pendulum Therapeutics as lead sponsor.

NCT NCT07566884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07566884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Phase Study on the Safety and Tolerance of a Novel Probiotic in Healthy Adults: Open-Label and Double-Blind, Placebo-Controlled Study
Lead sponsor
Pendulum Therapeutics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 23, 2024
Completion date
April 30, 2028
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults